NEXT Life Sciences
Latest round
- Seed
Last raised
- Jan 2024
Total raised
- $2.5M
Investors
- 7
About NEXT Life Sciences
a. NEXT Life Sciences is developing a procedure to bring a non-hormonal, long-lasting, and reversible male contraception solution. In January 2025, NEXT Life Sciences, Inc.R. Fox is the CEO of the company. The company provides Plan A™, which is a reversible birth control for men. The Plan A™ treatment is comparable to a no-scalpel vasectomy, with the exception that the hydrogel serves as a flexible filter to stop the passage of sperm, preventing pregnancy rather than irreversibly severing the vas deferens.
Who invested in NEXT Life Sciences
7 investors across 1 round
See all investors in NEXT Life Sciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 16, 2024
Amount
$2.5M
Investors
Questions about NEXT Life Sciences
Who invested in NEXT Life Sciences?
NEXT Life Sciences has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NEXT Life Sciences raised?
NEXT Life Sciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NEXT Life Sciences last raise money?
NEXT Life Sciences's most recent round on record is a Seed, in Jan 2024.
What does NEXT Life Sciences do?
NEXT Life Sciences is a medical devices & equipment company.
Where is NEXT Life Sciences headquartered?
NEXT Life Sciences is headquartered in San Luis Obispo, US.
Which VCs invest in companies like NEXT Life Sciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at NEXT Life Sciences's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like NEXT Life Sciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.